ARTICLE | Company News
Lpath ophthalmic news
August 9, 2010 7:00 AM UTC
Lpath received a $3 million grant from the BRDG-SPAN program at NIH's National Eye Institute to support Phase II development of Lpath's iSONEP sphingomab for wet age-related macular degeneration (AMD...